These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 6798712)

  • 1. The comparison of in vivo plasma radioactivity clearance and 14CO2 breath elimination of model drugs in the rat: a study in regional hepatocyte function.
    Willson RA; Hart FE
    Toxicol Appl Pharmacol; 1981 Nov; 61(2):177-84. PubMed ID: 6798712
    [No Abstract]   [Full Text] [Related]  

  • 2. A model of cytochrome P-450-centered hepatic dysfunction in drug metabolism induced by cobalt-protoporphyrin administration.
    Muhoberac BB; Hanew T; Halter S; Schenker S
    Biochem Pharmacol; 1989 Nov; 38(22):4103-13. PubMed ID: 2512932
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aminopyrine breath test and zonal hepatic damage in rats.
    Farag MM; Volicer L
    Pharmacology; 1985; 31(6):309-17. PubMed ID: 3936064
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aminopyrine disposition: studies on breath, saliva, and urine of normal subjects and patients with liver disease.
    Hepner GW; Vesell ES
    Clin Pharmacol Ther; 1976 Dec; 20(6):654-60. PubMed ID: 991536
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of drug metabolism in hepatic disease: comparison of plasma kinetics of oral cyclobarbital and the intravenous aminopyrine breath test.
    Breyer-Pfaff U; Seyfert H; Weber M; Egberts EH
    Eur J Clin Pharmacol; 1984; 26(1):95-101. PubMed ID: 6143671
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of ageing on aminopyrine and caffeine breath tests in the rat.
    Feely J; Kelleher P; Odumosu A
    Fundam Clin Pharmacol; 1987; 1(6):409-12. PubMed ID: 3447929
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diabetes alters drug metabolism--in vivo studies in a streptozotozin-diabetic rat model.
    Zysset T; Sommer L
    Experientia; 1986 May; 42(5):560-2. PubMed ID: 3086116
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Experimental hepatobiliary injury. Comparison of in vivo drug elimination with in vitro drug-metabolizing enzyme capacity in the rat.
    Willson RA; Hart FE; Hew JT
    Dig Dis Sci; 1981 Jan; 26(1):50-9. PubMed ID: 6780282
    [No Abstract]   [Full Text] [Related]  

  • 9. Quantitative assessment of hepatic function by breath analysis after oral administration of (14C)aminopyrine.
    Hepner GW; Vesell ES
    Ann Intern Med; 1975 Nov; 83(5):632-8. PubMed ID: 1200495
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of ketoconazole on hepatic oxidative drug metabolism in the rat in vivo and in vitro.
    Meredith CG; Maldonado AL; Speeg KV
    Drug Metab Dispos; 1985; 13(2):156-62. PubMed ID: 2859162
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The [14C]-aminopyrine breath test. A comparison of different forms of analysis.
    Henry DA; Sharpe G; Chaplain S; Cartwright S; Kitchingman G; Bell GD; Langman MJ
    Br J Clin Pharmacol; 1979 Dec; 8(6):539-45. PubMed ID: 533576
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aminopyrine demethylation measured by breath analysis in cirrhosis.
    Bircher J; Küpfer A; Gikalov I; Preisig R
    Clin Pharmacol Ther; 1976 Oct; 20(4):484-92. PubMed ID: 975720
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Contrasting effects of halothane, isoflurane, and enflurane on in vivo drug metabolism in the rat.
    Wood M; Wood AJ
    Anesth Analg; 1984 Aug; 63(8):709-14. PubMed ID: 6465554
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The pharmacokinetic interaction of diethyl ether with aminopyrine in the rat.
    Hanew T; Schenker S; Meredith CG; Henderson GI
    Proc Soc Exp Biol Med; 1984 Jan; 175(1):64-9. PubMed ID: 6694970
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rate of drug metabolism in man measured by 14CO2-breath analysis.
    Platzer R; Galeazzi RL; Karlaganis G; Bircher J
    Eur J Clin Pharmacol; 1978 Dec; 14(4):293-9. PubMed ID: 153232
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma levels of parent drug and metabolites in the intravenous aminopyrine breath test.
    Breyer-Pfaff U; Harder M; Egberts EH
    Eur J Clin Pharmacol; 1982; 21(6):521-8. PubMed ID: 6804246
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of the cytochrome P-448 dependent liver enzyme system by a caffeine breath test.
    Wietholtz H; Voegelin M; Arnaud MJ; Bircher J; Preisig R
    Eur J Clin Pharmacol; 1981; 21(1):53-9. PubMed ID: 6800827
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of hepatic drug metabolism by norethindrone.
    Field B; Lu C; Hepner GW
    Clin Pharmacol Ther; 1979 Feb; 25(2):196-8. PubMed ID: 759072
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug pharmacokinetics and the carbon dioxide breath test.
    Lane EA; Parashos I
    J Pharmacokinet Biopharm; 1986 Feb; 14(1):29-49. PubMed ID: 3091807
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Abnormal aminopyrine metabolism in patients with hepatic neoplasm. Detection by breath test.
    Hepner GW; Uhlin SR; Lipton A; Harvey HA; Rohrer V
    JAMA; 1976 Oct; 236(14):1587-90. PubMed ID: 989131
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.